Your browser doesn't support javascript.
loading
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.
Janssen, J J W M; Löwenberg, B; Manz, M; Biemond, B J; Westerweel, P E; Klein, S K; Fehr, M; Sinnige, H A M; Efthymiou, A; Legdeur, M C J C; Pabst, T; Gregor, M; van der Poel, M W M; Deeren, D; Tick, L W; Jongen-Lavrencic, M; van Obbergh, F; Boersma, R S; de Weerdt, O; Chalandon, Y; Heim, D; Spertini, O; van Sluis, G; Graux, C; Stüssi, G; van Norden, Y; Ossenkoppele, G J.
Afiliación
  • Janssen JJWM; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, loc. VUmc, Amsterdam, The Netherlands. j.janssen@amsterdamumc.nl.
  • Löwenberg B; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Manz M; USZ Zürich, Zürich, Switzerland.
  • Biemond BJ; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.
  • Westerweel PE; Department of Hematology, Amsterdam University Medical Centers, loc. AMC, Amsterdam, The Netherlands.
  • Klein SK; Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Fehr M; Department of Hematology, University Medical Center, Groningen, The Netherlands.
  • Sinnige HAM; Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Efthymiou A; Jeroen Bosch Hospital, Den Bosch, The Netherlands.
  • Legdeur MCJC; HFR, Fribourg, Switzerland.
  • Pabst T; Medisch Spectrum Twente, Enschede, The Netherlands.
  • Gregor M; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.
  • van der Poel MWM; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland.
  • Deeren D; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.
  • Tick LW; KSL, Luzern, Switzerland.
  • Jongen-Lavrencic M; Dept. of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • van Obbergh F; AZ Delta, Roeselare, Belgium.
  • Boersma RS; Maxima Medical Center, Eindhoven, The Netherlands.
  • de Weerdt O; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Chalandon Y; Hospital Saint Paul Jolimont, Haine, Belgium.
  • Heim D; Amphia Hospital, Breda, The Netherlands.
  • Spertini O; Antonius Hospital, Nieuwegein, The Netherlands.
  • van Sluis G; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.
  • Graux C; Division of Hematology, Department of Oncology, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Stüssi G; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.
  • van Norden Y; University Hospital, Basel, Switzerland.
  • Ossenkoppele GJ; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.
Leukemia ; 36(9): 2189-2195, 2022 09.
Article en En | MEDLINE | ID: mdl-35869267
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido